Product Information
Name:4-Bromo-6-chloropyridazin-3(2H)-one
Brand:Biosynth
Description:4-Bromo-6-chloropyridazin-3(2H)-one is a glycosylation inhibitor and nucleoside analog that can be used in the treatment of cancer. It inhibits the synthesis of deoxyribonucleotides from ribonucleotides by binding to the enzyme ribonucleotide reductase, which catalyzes the conversion of ribonucleotides to deoxynucleotides. 4-Bromo-6-chloropyridazin-3(2H)-one has been shown to inhibit glycosylation in rat liver cells. This drug also inhibits acetone and glycosidation, which are reactions that produce glucose from amino acids or carbohydrates. The crystallization process is also inhibited by this drug because it prevents the formation of nucleoside crystals, which are involved in DNA replication and cell division.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:209.43 g/mol
Formula:C4H2BrClN2O
Purity:Min. 95%
Technical inquiry about: 4-Bromo-6-chloropyridazin-3(2H)-one
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
